NO180046C - Markerte fibrinogen-reseptor-antagonister, og deres anvendelse - Google Patents
Markerte fibrinogen-reseptor-antagonister, og deres anvendelseInfo
- Publication number
- NO180046C NO180046C NO931528A NO931528A NO180046C NO 180046 C NO180046 C NO 180046C NO 931528 A NO931528 A NO 931528A NO 931528 A NO931528 A NO 931528A NO 180046 C NO180046 C NO 180046C
- Authority
- NO
- Norway
- Prior art keywords
- fibrinogen
- receptor antagonists
- fibrinogen receptor
- receptor
- labelled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4213930 | 1992-04-28 | ||
DE4214245A DE4214245A1 (de) | 1992-04-30 | 1992-04-30 | Tritiummarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zu ihrer herstellung |
Publications (4)
Publication Number | Publication Date |
---|---|
NO931528D0 NO931528D0 (no) | 1993-04-27 |
NO931528L NO931528L (no) | 1993-10-29 |
NO180046B NO180046B (no) | 1996-10-28 |
NO180046C true NO180046C (no) | 1997-02-05 |
Family
ID=25914315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931528A NO180046C (no) | 1992-04-28 | 1993-04-27 | Markerte fibrinogen-reseptor-antagonister, og deres anvendelse |
Country Status (16)
Country | Link |
---|---|
US (1) | US5677466A (xx) |
EP (1) | EP0567967B1 (xx) |
JP (1) | JPH0650977A (xx) |
KR (1) | KR940005271A (xx) |
AT (1) | ATE140225T1 (xx) |
AU (1) | AU670778B2 (xx) |
CA (1) | CA2094963A1 (xx) |
DE (1) | DE59303178D1 (xx) |
DK (1) | DK0567967T3 (xx) |
ES (1) | ES2092170T3 (xx) |
FI (1) | FI931881A (xx) |
GR (1) | GR3020740T3 (xx) |
IL (1) | IL105519A0 (xx) |
MX (1) | MX9302446A (xx) |
NO (1) | NO180046C (xx) |
NZ (1) | NZ247511A (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4304650A1 (de) * | 1993-02-16 | 1994-08-18 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4324580A1 (de) * | 1993-07-22 | 1995-01-26 | Thomae Gmbh Dr K | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5925635A (en) * | 1996-04-17 | 1999-07-20 | Dupont Pharmaceuticals Company | N-(amidinophenyl) cyclourea analogs as factor XA inhibitors |
IL136100A (en) * | 1997-11-20 | 2005-05-17 | Teijin Ltd | Biphenylamidine derivatives and pharmaceutical compositions containing the same |
KR20010032175A (ko) * | 1997-11-20 | 2001-04-16 | 야스이 쇼사꾸 | 비페닐아미딘 유도체 |
AU773156B2 (en) | 1999-01-28 | 2004-05-20 | Teijin Limited | Release-regulating preparations |
US6822101B2 (en) | 2002-09-16 | 2004-11-23 | Abbott Laboratories | Process for preparing amine-substituted benzofurans |
WO2004024707A2 (en) * | 2002-09-16 | 2004-03-25 | Abbott Laboratories | Process for preparing amine type substituted benzofurans |
EP3489692A1 (de) * | 2017-11-28 | 2019-05-29 | Siemens Healthcare Diagnostics Products GmbH | Prothrombinzeit-reagenz enthaltend einen eisenchelator |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4134467A1 (de) * | 1991-10-18 | 1993-04-22 | Thomae Gmbh Dr K | Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1993
- 1993-04-26 DK DK93106725.0T patent/DK0567967T3/da active
- 1993-04-26 ES ES93106725T patent/ES2092170T3/es not_active Expired - Lifetime
- 1993-04-26 EP EP93106725A patent/EP0567967B1/de not_active Expired - Lifetime
- 1993-04-26 AT AT93106725T patent/ATE140225T1/de not_active IP Right Cessation
- 1993-04-26 DE DE59303178T patent/DE59303178D1/de not_active Expired - Fee Related
- 1993-04-26 KR KR1019930006959A patent/KR940005271A/ko not_active Application Discontinuation
- 1993-04-27 JP JP5100789A patent/JPH0650977A/ja active Pending
- 1993-04-27 NZ NZ247511A patent/NZ247511A/en unknown
- 1993-04-27 AU AU37153/93A patent/AU670778B2/en not_active Ceased
- 1993-04-27 CA CA002094963A patent/CA2094963A1/en not_active Abandoned
- 1993-04-27 IL IL105519A patent/IL105519A0/xx unknown
- 1993-04-27 NO NO931528A patent/NO180046C/no unknown
- 1993-04-27 MX MX9302446A patent/MX9302446A/es not_active IP Right Cessation
- 1993-04-27 FI FI931881A patent/FI931881A/fi not_active Application Discontinuation
-
1995
- 1995-05-23 US US08/447,667 patent/US5677466A/en not_active Expired - Fee Related
-
1996
- 1996-08-07 GR GR960402105T patent/GR3020740T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3020740T3 (en) | 1996-11-30 |
FI931881A (fi) | 1993-10-29 |
US5677466A (en) | 1997-10-14 |
NO180046B (no) | 1996-10-28 |
IL105519A0 (en) | 1993-08-18 |
EP0567967A1 (de) | 1993-11-03 |
MX9302446A (es) | 1994-03-31 |
NZ247511A (en) | 1995-02-24 |
DK0567967T3 (da) | 1996-11-18 |
AU3715393A (en) | 1993-11-04 |
CA2094963A1 (en) | 1993-10-29 |
ES2092170T3 (es) | 1996-11-16 |
ATE140225T1 (de) | 1996-07-15 |
DE59303178D1 (de) | 1996-08-14 |
EP0567967B1 (de) | 1996-07-10 |
NO931528D0 (no) | 1993-04-27 |
JPH0650977A (ja) | 1994-02-25 |
NO931528L (no) | 1993-10-29 |
KR940005271A (ko) | 1994-03-21 |
AU670778B2 (en) | 1996-08-01 |
FI931881A0 (fi) | 1993-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Feltkamp | Conjugation of Fluorescein Isothiocyanate to Antibodies I. EXPERIMENT ON THE CONDITIONS OF CONJUGATION. | |
Mandle et al. | Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. | |
Leyte et al. | The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII | |
Takamatsu et al. | Identification of the thrombin receptor on human platelets by chemical crosslinking. | |
Terkeltaub et al. | Plasma protein binding by monosodium urate crystals | |
DK0397633T3 (da) | Fibronectinbindende protein samt fremstilling deraf | |
DE69841037D1 (de) | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. | |
DK0590071T3 (da) | Hovedsagelig rene receptor-lignende TGF-BETA-1 bindende molekyler samt anvendelse deraf | |
ATE128237T1 (de) | Test für hepatitis-c. | |
NO180046C (no) | Markerte fibrinogen-reseptor-antagonister, og deres anvendelse | |
DK0407813T3 (da) | Oxidativ denaturering af proteinanalytter | |
Karamanolis et al. | Characterization of cryofibrinogen isolated from patients’ plasma | |
DE68921371D1 (de) | Verfahren zur Herstellung einer an Faktor-VIIa angereicherten Fraktion und ihre Verwendung als Arzneimittel. | |
Kelm et al. | Human platelet osteonectin: release, surface expression, and partial characterization | |
Pihko et al. | Rabbit α-fetoprotein: Immunochemical purification and partial characterization | |
Gralnick et al. | Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease | |
ATE345381T1 (de) | Neue polypeptide aus bienengift und verfahren zu deren verwendung | |
ATE196775T1 (de) | Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon | |
SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
DK0738735T3 (da) | Aminoterminalt propeptid af type I procollagen, antistoffer dertil og analysemetode ved anvendelse deraf | |
Maire et al. | Purification of bovine conglutinin using pepsin digestion | |
Weinstein et al. | Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. | |
ATE281519T1 (de) | Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor) | |
Suzuki et al. | The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor | |
Hitschold et al. | Purification and physicochemical properties of C1q from guinea-pig serum |